Tiny radioactive seeds may offer new hope for women with recurrent pelvic cancer
NCT ID NCT07631572
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests a radiation treatment called Cesium-131 brachytherapy for women whose cervical or endometrial cancer has returned in the vagina after prior pelvic radiation. Tiny radioactive seeds are placed directly into the tumor to kill cancer cells while sparing healthy organs. The goal is to avoid major surgery that removes the bladder, rectum, and other pelvic organs. About 10 participants will be enrolled to see if this approach can control the cancer and preserve organ function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNECOLOGIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kentucky Markey Cancer Center
RECRUITINGLexington, Kentucky, 40506, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a personalized exercise program boost recovery in cancer survivors?
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Braids and conditioner may boost scalp cooling against chemo hair loss
- New imaging tool could help surgeons detect hidden cancer cells during surgery
- Could an ALS drug clear the fog of chemo brain?
- Could a chatbot help close the gap in genetic cancer testing?